Skip to main content

Detail

  1. Home
  2. Research
  3. Researcher Profiles
  4. Researcher Profiles
  5. Detail
Michael Krebs
Michael Krebs, MD

Department of Medicine III (Division of Endocrinology and Metabolism)
Position: Associate Professor

ORCID: 0000-0002-9265-7274
T +43 1 40400 43110
michael.krebs@meduniwien.ac.at

Keywords

Adrenal Glands; Bariatric Medicine; Endocrinology; Glucose Clamp Technique; Glucose Metabolism Disorders; Insulin Resistance; Magnetic Resonance Spectroscopy; Obesity, Morbid; Phenotype; Pituitary Diseases; Pituitary Function Tests; Thyroid Diseases

Research group(s)

Research interests

During the recent years we have performed studies on glucose metabolism in normal volunteers and diabetic subjects using NMR spectroscopy (non-invasive determination of glycogen concentrations in skeletal muscle and liver, muscular glucose-6-phosphate, and intracellular lipids). Our group also applies various tracer techniques and biopsies of skeletal muscle in combination with hyperinsulinemic- and pancreatic-clamp tests to determine rates of glucose turnover, gluconeogenesis, and molecular mechanisms insulin resistance. We am especially interested in elucidating the mechanisms of nutrient induced insulin resistance in humans.  A major focus of my research work was the pathogenesis of vascular and myocardial disease associated with the insulin resistance syndrome and type 2 diabetes. 

Techniques, methods & infrastructure

  • Metabolic  NMR spectroscopy in vivo
  • Comprehensive metabolic phenotyping (Clamp Studies, Biopsies)

Selected publications

  1. Smajis, S. et al., 2019. Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects. The American Journal of Clinical Nutrition, 111(2), pp.369–377. Available at: http://dx.doi.org/10.1093/ajcn/nqz271.
  2. Scherer, T. et al., 2017. Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects. The Journal of Clinical Endocrinology & Metabolism, 102(4), pp.1325–1332. Available at: http://dx.doi.org/10.1210/jc.2016-3623.
  3. Beiglböck, H. et al., 2020. Effects of Thyroid Function on Phosphodiester Concentrations in Skeletal Muscle and Liver: An In Vivo NMRS Study. The Journal of Clinical Endocrinology & Metabolism, 105(12), pp.e4866–e4874. Available at: http://dx.doi.org/10.1210/clinem/dgaa663.
  4. Wolf, P. et al., 2019. Identifying a disease-specific renin–angiotensin–aldosterone system fingerprint in patients with primary adrenal insufficiency. European Journal of Endocrinology, 181(1), pp.39–44. Available at: http://dx.doi.org/10.1530/EJE-19-0086.
  5. Wolf, P. et al., 2020. Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition. Diabetes Care, 44(2), pp.541–548. Available at: http://dx.doi.org/10.2337/dc20-1983.